Bracebridge Capital LLC’s Tevogen Inc Warrant TVGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$710 Hold
12,500
﹤0.01% 40
2026
Q1
$424 Hold
12,500
﹤0.01% 44
2025
Q4
$528 Hold
12,500
﹤0.01% 37
2025
Q3
$694 Hold
12,500
﹤0.01% 35
2025
Q2
$874 Hold
12,500
﹤0.01% 44
2025
Q1
$674 Hold
12,500
﹤0.01% 37
2024
Q4
$675 Hold
12,500
﹤0.01% 40
2024
Q3
$161 Hold
12,500
﹤0.01% 39
2024
Q2
$369 Hold
12,500
﹤0.01% 39
2024
Q1
$1.03K Hold
12,500
﹤0.01% 40
2023
Q4
$500 Hold
12,500
﹤0.01% 43
2023
Q3
$625 Hold
12,500
﹤0.01% 48
2023
Q2
$516 Hold
12,500
﹤0.01% 63
2023
Q1
$1.13K Buy
+12,500
New +$691 ﹤0.01% 71

Other funds holding TVGNW

Bracebridge Capital LLC's TVGNW Position: Q2 2026 in Review

Bracebridge Capital LLC held its Tevogen Inc Warrant (TVGNW) position steady in Q2 2026 at 12,500 shares worth $710. The position accounts for ﹤0.01% of the portfolio, ranked #40.

Bracebridge Capital LLC first reported a position in TVGNW in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.13K in Q1 2023. 33 funds tracked by Wall St. Rank hold TVGNW as of Q2 2026.

  • Bracebridge Capital LLC held 12,500 shares of Tevogen Inc Warrant worth $710 as of Q2 2026.
  • Bracebridge Capital LLC left its Tevogen Inc Warrant share count unchanged in Q2 2026.
  • Tevogen Inc Warrant made up ﹤0.01% of Bracebridge Capital LLC's portfolio in Q2 2026, its #40 holding.
  • Bracebridge Capital LLC first reported a position in Tevogen Inc Warrant in Q1 2023 and has held it in 14 quarters since.
  • Bracebridge Capital LLC's Tevogen Inc Warrant position peaked at $1.13K in Q1 2023.
  • 33 funds tracked by Wall St. Rank held Tevogen Inc Warrant as of Q2 2026.

Based on Bracebridge Capital LLC's 13F filing for Q2 2026, filed 14 Aug 2026.